查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585637

生物植入市場：按產品、管理方法和應用 - 全球預測 2025-2030

Biological Implants Market by Product (Allografts, Autografts, Xenografts), Mode of Administration (Injectable, Surgical), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年生物植入市場規模為337.3億美元，預計2024年將達409億美元，複合年成長率為21.36%，到2030年將達到1308.4億美元。

生物植入是指植入體內以取代或補充自然功能的裝置或組織。這些植入包括廣泛的產品，包括整形外科植入、牙科植入、心血管植入和神經植入。對生物植入的需求不斷增加是由於與老齡化相關的疾病、慢性疾病和事故的增加導致了對此類醫療干預的需求。最終用途多種多樣，包括醫院、診所和專業研究中心。市場成長主要受到糖尿病、癌症、心血管疾病、整形外科疾病盛行率不斷上升、醫療技術進步以及全球人口老化的影響。結合生物活性化合物和改善生物相容性的新材料代表了技術創新的重大機會。此外，數位健康技術（例如 3D 列印和生物列印）的整合為自訂的、針對患者的植入開闢了新的擴展和適應途徑。

主要市場統計
基準年[2023] 337.3億美元
預測年份 [2024] 409億美元
預測年份 [2030] 1308.4億美元
複合年成長率（%） 21.36%

市場成長面臨的主要限制和挑戰包括植入式設備的高成本、複雜的監管核准流程以及可能導致不良免疫反應的生物相容性問題。這些因素可能會影響市場准入並延遲新產品的推出。創新應著重於開發具有成本效益的生產技術，透過仿生材料提高生物相容性，並利用奈米技術提高性能。公司應該投資與學術機構的研究合作夥伴關係，以保持在材料科學和再生醫學進步的最前沿。市場競爭激烈，領先公司不斷尋求透過合併、收購和合作來擴大產品系列。公司還應專注於客製化以滿足患者的特定需求並改善當地監管和報銷條件。這項策略方針將有助於確保市場滲透並利用新興經濟體不斷成長的商機。

市場動態：揭示快速發展的生物植入市場的關鍵市場洞察

供需的動態交互作用正在改變生物植入市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 精密植入手術的重大進展
    • 人口老化加劇，整形外科疾病、脊椎疾病等疾病的發生
    • 人們對美容植入的認知不斷增強
  • 市場限制因素
    • 製造成本高
  • 市場機會
    • 3D列印和雷射技術等技術創新
    • 再生醫學和組織工程的進展
  • 市場挑戰
    • 報銷不暢問題

波特五力：駕馭生物植入市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生物植入市場的外部影響

外部宏觀環境因素在塑造生物植入市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解生物植入市場的競爭格局

對生物植入市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣生物植入市場供應商的績效評估

FPNV 定位矩陣是評估生物植入市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了生物植入市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對生物植入市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 精密植入手術的重大進展
      • 人口老化加劇，整形外科疾病、脊椎疾病等疾病增加
      • 提高人們對美容植入的認知
    • 抑制因素
      • 生產成本高
    • 機會
      • 3D列印和雷射技術等技術創新
      • 再生醫學和組織工程的進展
    • 任務
      • 很少有退款問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章生物植入市場：依產品

  • 同種異體移植
  • 自體移植
  • 異種移植

第7章 生物植入市場管理方式

  • 可注射的
  • 外科手術

第8章生物植入市場：依應用分類

  • 心血管植入
  • 整形外科植入
  • 軟組織植入物

第9章美洲生物植入市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太生物植入市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲生物植入市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Allografts.com
  • Alphatec Spine, Inc.
  • Altogen Labs
  • Auto Tissue Berlin GmbH
  • Baxter International, Inc.
  • BioPolymer GmbH & Co. KG
  • Citagenix Inc.
  • Conmed Corporation
  • CryoLife, Inc.
  • Edward LifeSciences Corporation
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • KLS Martin, LP by Leibinger family
  • Medical Device Business Services, Inc.
  • Medtronic PLC
  • NuVasive, Inc. by Globus Medical Inc
  • RTI Surgical, Inc.
  • Sanara MedTech, Inc.
  • Stryker Corporation
  • Surgenex LLC
  • TissueTech, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-ED54C46E8D5E

The Biological Implants Market was valued at USD 33.73 billion in 2023, expected to reach USD 40.90 billion in 2024, and is projected to grow at a CAGR of 21.36%, to USD 130.84 billion by 2030.

Biological implants refer to devices or tissues that are inserted into the body to replace or assist a natural function. These implants encompass a wide range of products, including orthopedic implants, dental implants, cardiovascular implants, and neural implants, among others. The growing necessity for biological implants stems from the rise in age-related conditions, chronic diseases, and accidents resulting in the need for such medical interventions. End-use applications are extensive, spanning across hospitals, clinics, and specialized research centers. Market growth is primarily influenced by the increasing prevalence of diabetes, cancer, cardiovascular diseases, and orthopedic disorders, paired with advancements in medical technology and an aging global population. New materials incorporating bioactive compounds and improved bio-compatibility present significant opportunities for innovation. Moreover, the integration of digital health technologies such as 3D printing and bioprinting for custom and patient-specific implants opens up new routes for expansion and adaptation.

KEY MARKET STATISTICS
Base Year [2023] USD 33.73 billion
Estimated Year [2024] USD 40.90 billion
Forecast Year [2030] USD 130.84 billion
CAGR (%) 21.36%

The major limitations and challenges facing market growth include the high cost of implantable devices, complex regulatory approval processes, and potential biocompatibility issues, which could lead to adverse immune responses. These factors can affect market accessibility and slow down the introduction of new products. Innovations should focus on developing cost-effective production techniques, enhancing biocompatibility through biomimetic materials, and leveraging nanotechnology for improved performances. Businesses should invest in research partnerships with academic institutions to stay at the forefront of material science and regenerative medicine advancements. The nature of the market is competitive, with major players constantly seeking to expand their product portfolios through mergers, acquisitions, and collaborations. Companies should also focus on addressing patient-specific needs through customization and improving regulatory and reimbursement landscapes across different regions. This strategic approach will ensure market penetration and capitalize on the expanding opportunities within emerging economies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biological Implants Market

The Biological Implants Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Significant advancement in precise implant surgical procedures
    • Increasing aging population coupled with instances of diseases such as orthopedic and spinal disorders
    • Rising awareness of cosmetic implants
  • Market Restraints
    • High production cost
  • Market Opportunities
    • Technological innovations such as 3D printing and laser technology
    • Advancements in regenerative medicine and tissue engineering
  • Market Challenges
    • Scant reimbursement issues

Porter's Five Forces: A Strategic Tool for Navigating the Biological Implants Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biological Implants Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biological Implants Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biological Implants Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biological Implants Market

A detailed market share analysis in the Biological Implants Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biological Implants Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biological Implants Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biological Implants Market

A strategic analysis of the Biological Implants Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biological Implants Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Allografts.com, Alphatec Spine, Inc., Altogen Labs, Auto Tissue Berlin GmbH, Baxter International, Inc., BioPolymer GmbH & Co. KG, Citagenix Inc., Conmed Corporation, CryoLife, Inc., Edward LifeSciences Corporation, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KLS Martin, L.P. by Leibinger family, Medical Device Business Services, Inc., Medtronic PLC, NuVasive, Inc. by Globus Medical Inc, RTI Surgical, Inc., Sanara MedTech, Inc., Stryker Corporation, Surgenex LLC, TissueTech, Inc., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Biological Implants Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Allografts, Autografts, and Xenografts.
  • Based on Mode of Administration, market is studied across Injectable and Surgical.
  • Based on Application, market is studied across Cardiovascular Implants, Orthopedic Implants, and Soft Tissue Implants.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant advancement in precise implant surgical procedures
      • 5.1.1.2. Increasing aging population coupled with instances of diseases such as orthopedic and spinal disorders
      • 5.1.1.3. Rising awareness of cosmetic implants
    • 5.1.2. Restraints
      • 5.1.2.1. High production cost
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological innovations such as 3D printing and laser technology
      • 5.1.3.2. Advancements in regenerative medicine and tissue engineering
    • 5.1.4. Challenges
      • 5.1.4.1. Scant reimbursement issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biological Implants Market, by Product

  • 6.1. Introduction
  • 6.2. Allografts
  • 6.3. Autografts
  • 6.4. Xenografts

7. Biological Implants Market, by Mode of Administration

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Surgical

8. Biological Implants Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Implants
  • 8.3. Orthopedic Implants
  • 8.4. Soft Tissue Implants

9. Americas Biological Implants Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biological Implants Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Biological Implants Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Allografts.com
  • 3. Alphatec Spine, Inc.
  • 4. Altogen Labs
  • 5. Auto Tissue Berlin GmbH
  • 6. Baxter International, Inc.
  • 7. BioPolymer GmbH & Co. KG
  • 8. Citagenix Inc.
  • 9. Conmed Corporation
  • 10. CryoLife, Inc.
  • 11. Edward LifeSciences Corporation
  • 12. Integra LifeSciences Corporation
  • 13. Johnson & Johnson Services, Inc.
  • 14. KLS Martin, L.P. by Leibinger family
  • 15. Medical Device Business Services, Inc.
  • 16. Medtronic PLC
  • 17. NuVasive, Inc. by Globus Medical Inc
  • 18. RTI Surgical, Inc.
  • 19. Sanara MedTech, Inc.
  • 20. Stryker Corporation
  • 21. Surgenex LLC
  • 22. TissueTech, Inc.
  • 23. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOLOGICAL IMPLANTS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOLOGICAL IMPLANTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIOLOGICAL IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIOLOGICAL IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOLOGICAL IMPLANTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOLOGICAL IMPLANTS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY AUTOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY XENOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SOFT TISSUE IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. BIOLOGICAL IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. BIOLOGICAL IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023